/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Peter van der Meer is a cardiologist, chair of the Department of Experimental Cardiology and professor of Heart Failure and Translational Cardiology at the University of Groningen.
Professor van der Meer received both his MD and PhD cum laude and completed a postdoctoral fellowship at Harvard Medical School, Boston, MA, USA. He authored >300 manuscripts, has an H-index of >100 and was member of the 2022 ESC CardioOncology guidelines and is member of the ESC/HFA working group on PeriPartum CardioMyopathy. He is a member of several steering committees of large phase 3 trials. His research is funded by national and international grants including an ERC CoG grant. His research group consists of PhD students and post-docs with various backgrounds (biologists, medical doctors and biomedical-engineers) working on translational research topics. His research focusses on understanding the susceptibility to develop heart failure and on exploring novel treatment targets and therapies.
